Brief: Sino Biopharmaceutical Says Purchased Aggregate Of 78.4 Million Shares Under Share Purchase Plan
24/01/2024 15:26
Jan 24 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK :
* FROM 3 OCT 2023 TO 24 JAN 2024, PURCHASED AGGREGATE OF
78.4
MILLION SHARES UNDER SHARE PURCHASE PLAN
* PURCHASE OF SHARES FOR HK$234 MILLION
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsBrief: Sino Biopharmaceutical Announces Share Purchase Plan For HK$2 Billion
Brief: Sino Biopharmaceutical Says Marketing Application For M701 Accepted By China In May 2026
Brief: Sino Biopharmaceutical Says Zongertinib Approved By NMPA China
GSK to team up with Sino Biopharma for China launch of hepatitis B treatment (updated)
HK-listed Sino Biopharmaceutical hits 2-week high on GSK tie-up